Open-label placebo offers new treatment for disorders of gut-brain interaction in children
Pain-predominant disorders of gut-brain interaction (DGBIs) in children—such as functional abdominal pain (FAP) and irritable bowel syndrome (IBS)— can lead to disabling symptoms, poor quality of life and high use of ...
Jan 31, 2022
0
14